DWA
WST icon

Dorsey Wright & Associates’s West Pharmaceutical WST Stock Holding History

Dorsey Wright & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,157
Closed -$1.56M – 288
2023
Q3 		$1.56M Sell
4,157
-13
-0.3% -$5.03K 0.49% 92
2023
Q2 		$1.59M Buy
+4,170
New +$1.49M 0.48% 95
2022
Q2 		– Sell
-7,110
Closed -$2.92M – 330
2022
Q1 		$2.92M Sell
7,110
-5,993
-46% -$2.35M 0.68% 76
2021
Q4 		$6.14M Buy
13,103
+4,805
+58% +$2.07M 1.27% 18
2021
Q3 		$3.52M Buy
+8,298
New +$3.5M 0.77% 56
2021
Q1 		– Sell
-10,953
Closed -$3.1M – 379
2020
Q4 		$3.1M Buy
10,953
+43
+0.4% +$12.1K 0.46% 68
2020
Q3 		$3M Sell
10,910
-4,691
-30% -$1.24M 0.54% 58
2020
Q2 		$3.53M Buy
15,601
+3,046
+24% +$598K 0.72% 36
2020
Q1 		$1.91M Buy
+12,555
New +$1.93M 0.72% 70
2018
Q1 		– Sell
-29,329
Closed -$2.89M – 144
2017
Q4 		$2.89M Buy
29,329
+984
+3% +$96.5K 0.52% 69
2017
Q3 		$2.73M Buy
28,345
+206
+0.7% +$18.6K 0.63% 71
2017
Q2 		$2.66M Buy
28,139
+318
+1% +$29.2K 0.82% 50
2017
Q1 		$2.27M Buy
27,821
+1,825
+7% +$153K 0.78% 37
2016
Q4 		$2.21M Sell
25,996
-15,215
-37% -$1.2M 0.94% 33
2016
Q3 		$3.07M Buy
41,211
+2,669
+7% +$212K 1.46% 23
2016
Q2 		$2.92M Buy
+38,542
New +$2.8M 1.56% 20

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Dorsey Wright & Associates's WST Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 4,157 shares — an estimated $1.56M sold.

Dorsey Wright & Associates first reported a position in WST in Q2 2016 and held it in 16 quarters. The position peaked at $6.14M in Q4 2021. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 4,157 West Pharmaceutical shares in Q4 2023, an estimated $1.56M.
  • Dorsey Wright & Associates first reported a position in West Pharmaceutical in Q2 2016 and held it in 16 quarters.
  • Dorsey Wright & Associates's West Pharmaceutical position peaked at $6.14M in Q4 2021.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.